Shwachman-Diamond syndrome is an autosomal recessive disorder characterized by exocrine pancreatic dysfunction, bony metaphyseal dysostosis, various degrees of cytopenia, and a striking tendency to develop myelodysplastic syndrome and acute myeloblastic leukemia. Isochromosome 7 [i(7q)] is a rare non-random cytogenetic abnormality of myeloid cells in hematological malignancy. We report two cases of Shwachman-Diamond syndrome in which patients developed myelodysplastic syndrome and i(7q), detected by G-banding karyotype analysis and fluorescence in situ hybridization. Three other children have been previously reported to have myelodysplastic syndrome in association with i(7q); two of them had Shwachman-Diamond syndrome. Isochromosome 7q may be a fairly specific marker of myeloid malignant transformation in this syndrome and play a role in its pathogenesis.
Introduction
Shwachman-Diamond syndrome (SDS) is a multisystemic autosomal recessive disorder characterized by exocrine pancreatic dysfunction, bony metaphyseal dysostosis, and various hematological manifestations. These include varying degrees of cytopenia and a marked tendency in up to one-third of patients to develop myelodysplastic syndrome (MDS) and acute myeloblastic leukemia. 1 Isochromosome 7q [i(7q)] is a rare cytogenetic abnormality of bone marrow myeloid cells associated with hematological malignancy. We report two cases of SDS complicated by MDS and i(7q) and relate them to two earlier reported cases of a similar abnormality.
Case reports

Case 1
A 10-month-old boy presented with steatorrhea due to exocrine pancreatic insufficiency, severe intermittent neutropenia and moderate thrombocytopenia. Pancreatic stimulation test results were abnormal, and a diagnosis of SDS was made. Additional findings included reactive airway disease, mildly elevated hepatic transaminases, right supernumerary thumb and severe dental caries. The boy had not suffered from severe infectious complications. He was treated with oral pancreatic enzymes and fat-soluble vitamins. Cytogenetic analysis of peripheral lymphocytes was normal. Bone marrow examination, performed at diagnosis, showed a hypoplastic specimen with decreased myelocytic precursors. 
Case 2
A 4-month-old boy presented with steatorrhea and intermittent neutropenia. Pancreatic stimulation test results were abnormal, and a diagnosis of SDS was made. He had no evidence of metaphyseal dysostosis on skeletal survey. Bone marrow examination at diagnosis showed a hypoplastic specimen, a relative decrease in the number of mature myeloid forms, and prominent mast cells. The boy has not had severe bacterial infections but requires supplemental pancreatic enzymes. At the age of 5 years, as part of the surveillance program, he underwent routine bone marrow aspiration and biopsy, which again showed a hypoplastic specimen. The myeloid precursors were decreased in number with dysplastic changes. Blasts constituted 5% of the nucleated cells. Mast cells were again prominent. Because of the presence of the cytogenetic abnormalities described (see Results) he is also awaiting bone marrow transplant from a matched unrelated donor.
Methods
G-banding analysis
Freshly obtained bone marrow cells collected in preservativefree heparin were analyzed for cytogenetic abnormalities. Both direct (uncultured) cells and 24-h cultures were then harvested using standard protocols. 3 Metaphases were analyzed using a conventional GTG-banding method. ISCN 1995 criteria were used to define abnormal clones. 4 
Fluorescence in situ hybridization (FISH) analysis
Slides made from the bone marrow samples were prewarmed in 2 × SSC (1 × SSC = 0.15 M NaCl/0.15 M sodium citrate) pH 7.0 at 37°C for 30 min. The slides were then dehydrated in ethanol and denatured in a solution of 70% formamide in 2 × SSC at 70°C, as previously described. 5 Slides were hybridized to commercially available probes at 37°C in a humidified chamber overnight. A DNA probe specific to locus D7S522 at 7q31 directly labeled with spectrum orange LSI D75522 (Vysis, Downers Grove, IL, USA) and centromer spectrum green D7Z1 (Vysis) were used. The slides were then washed with 0. 4 painting was performed using whole chromosome painting probe for chromosome 7 (WCP7; Oncor, Gaithersburg, MD, USA) to identify 7q abnormalities on metaphase preparations from patient 2.
Results
G-banding analysis
For patient 1, 7 metaphase cells were analyzed and all showed 46,XY,i(7)(q10) (Figure 1a) . For patient 2, 20 metaphase cells were analyzed: two showed 46,XY,i(7)(q10) (Figure 2a) , 11 showed 46,XY,del(20)(q11), and seven showed normal male karyotype.
FISH analysis
For patient 1, interphase FISH was performed using a 7(q)- 
Discussion
A review of the medical literature in English revealed 14 patients with SDS that transformed into MDS/acute myeloid leukemia with abnormal bone marrow cytogenetic studies. 1, [6] [7] [8] [9] Nine of these patients had cytogenetic abnormalities involving chromosome 7 (Table 1 ). These cases suggest that a substan- tial portion of patients with SDS who develop MDS/acute myeloid leukemia will also exhibit chromosome 7 abnormalities. In this report we describe two children with SDS who acquired I(7q). I(7q) has been reported only in three children with myelodysplasia; 1,9,10 and interestingly two of them also had SDS. 1, 9 The third child developed pancytopenia and hypoplastic bone marrow at age 5 years but did not have pancreatic insufficiency, although his height and weight were below the 5th percentile for age. 10 This rare structural aberration of chromosome 7 is completely different from the more common form, monosomy 7, but both seem to be related to the development of malignant myeloid transformation.
An isochromosome consists of two identical copies of one chromosome arm. It is caused by either abnormal splitting of the centromere during mitosis 11 or a propensity of sequences in one proximal arm for breakage and reunion events between sister chromatids or homologous chromosomes. 12 This results in a loss of one arm while the other is duplicated to form one symmetric chromosome with two genetically identical arms. Thus an isochromosome for the long arm of number 7 -i(7q) -contains two copies of the long arm separated by a centromere. This structural abnormality leads to monosomy for the genes on 7p and trisomy for those on 7q.
The mechanism by which chromosome 7 abnormalities contribute to the pathogenesis of malignant myeloid transformation is not known. Since the common forms of chromosome 7 abnormalities involve deletion of 7q, and since trisomy of this arm occurs in i(7q), disruption of proximal genes on 7q is a possible mechanism. Possible candidate genes are the human homologues of the yeast DNA mismatch repair gene PMS2 at 7q11.22-23, 13 mutations of which are found in hereditary nonpolyposis colon cancer.
14 Another leukemogenic mechanism might be a loss of gene(s) on the short arm of chromosome 7 such as human PMS2 gene, a replicate of which maps to 7p22.
14 Alternatively, chromosome 7 abnor-malities may merely be an epiphenomenon associated with myeloid malignancies but not directly involved in their pathogenesis, being prone to breakage once the malignant transformation occurs. Interestingly, Smith et al's patient and patient 1 in the present study had i(7q) as the sole abnormality, a finding that supports the hypothesis of a mechanistic role of the chromosome 7 abnormality in the multistep pathogenesis of the malignant transformation. It is noteworthy that our patient 2 exhibited i(7q) as a minor clone; the majority of the abnormal cells showed del(20)(q11), another chromosomal abnormality reported in MDS. 15 Chromosome 7 abnormalities are common in a variety of conditions with a propensity for MDS, including congenital bone marrow disorders such as SDS and Kostmann's syndrome and acquired conditions such as severe aplastic anemia. 16 The broad spectrum of underlying predispositions associated with chromosome 7 abnormalities suggests that these aberrations are secondary events that contribute to the development of leukemia. The genetic defect and molecular basis for SDS that predisposes patients to changes in chromosome 7, and the genes on chromosome 7 responsible for the malignant transformation, require definition.
